Nanjing Medical University
Clinical trials sponsored by Nanjing Medical University, explained in plain language.
-
Armored immune cells take on deadly brain tumor in first human test
Disease control Not yet recruitingThis early-phase study tests a new treatment for malignant meningioma, a rare and aggressive brain tumor. Researchers combine special immune cells (γδ T cells) with a PD-1 antibody to help them attack the tumor. The study will enroll 12 adults whose tumor has returned, to check i…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Vitamin b pills may shield heart surgery patients from deadly events
Disease control Not yet recruitingThis study tests whether taking vitamin B supplements before and after heart surgery can lower the risk of major heart problems like heart attack, stroke, or severe irregular heartbeat. About 1,000 adults aged 18 to 80 having heart surgery will take either vitamin B or a placebo …
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
AI could personalize emergency treatment for deadly aortic tears
Disease control Not yet recruitingThis study tests whether using artificial intelligence to guide anti-inflammatory treatment can improve outcomes for people with acute aortic dissection, a life-threatening tear in the aorta. 300 patients will be randomly assigned to receive either AI-personalized therapy or stan…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Mind over matter: exercise and meditation may soothe chemo nerve damage
Symptom relief Not yet recruitingThis study tests whether a program combining exercise and mindfulness-based therapy can reduce nerve pain and emotional distress in cancer patients who have nerve damage from chemotherapy. Forty adults with early-stage cancer and chemotherapy-induced peripheral neuropathy will fo…
Phase: NA • Sponsor: Nanjing Medical University • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Scientists to map tumor changes after Chemo-Immunotherapy in esophageal cancer
Knowledge-focused Not yet recruitingThis study looks at how the area around esophageal tumors changes after standard chemotherapy combined with immunotherapy and before surgery. Researchers will collect tumor samples before and after treatment from 12 participants and use advanced genetic tools to study cell change…
Sponsor: Nanjing Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC
-
Thyroid trouble may warn of diabetes risk, new study hopes to learn how
Knowledge-focused Not yet recruitingThis study looks at adults aged 18-60 with autoimmune thyroid disease to see if they are also at risk for type 1 diabetes. Researchers will test blood for diabetes-related antibodies and genes. The goal is to better understand the link between these two autoimmune conditions, not…
Sponsor: Nanjing Medical University • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC